Claire Dwoskin Interviewed At AutismOne Conference

In July 2014, the annual AutismOne Conference was held at the InterContinental Chicago O’Hare Hotel in Rosemont, IL where Claire Dwoskin and Dr. Stephanie Seneff were in attendance. AutismOne is the premier networking center of the autism advocacy and science community, where researchers, doctors and parents come together to share support and ideas with each other. While Mrs. Dwoskin and Dr. Seneff participated in various engagements, Mrs. Dwoskin was interviewed by an AutismOne host, Leslie Carol Botha, who brought to light the important mission behind CMSRI.

During the interview, Dwoskin explains that the foundation was created to address various eroding national health issues that include conditions like autism, Alzheimer’s disease, autoimmune diseases, food allergies, asthma and many others. With that being said, 54 percent of all children today have some type of chronic health condition, which also includes obesity. Additionally, 90 percent of those children with chronic health conditions continue to suffer from these conditions beyond the age of 18. The U.S. healthcare system was not designed to care for such large numbers of chronically ill and disabled children who will remain in need of daily use medicines or therapies throughout their lifetimes. In decades past, people did not become heavy users of the healthcare system until after the age of 50; now, we are seeing children being as heavy or heavier users of the healthcare system than was previously documented.

With this in mind, the chronic illness and disability epidemic puts a debilitating burden on parent’s shoulders in terms of financial stability. Some parents have to stay home to care for their child 24/7, and to add to this economic penalty, there is the constant need for multiple doctors’ appointments. The medical bills pile up, and chronic health conditions spiral into many issues that can affect the whole family. Parents are increasingly despairing of the emotional and financial toll these health conditions exact on their marriages and family life, and are resorting to drastic and desperate actions such as faced by Alex Spourdelakis’ parents. His tragic story is poignantly told in the documentary film, “Who Killed Alex Spourdelakis.” Additionally, parents have collectively shared their stories of suffering through the #hearthiswell campaign.

Addressing the causal factors of chronic health conditions is CMSRI’s mission, because raising awareness of the causal factors so that they can be avoided could potentially reduce the number of children being diagnosed with these debilitating and often deadly conditions.

CMSRI funds research on the causal factors underlying chronic health conditions, because it’s just not enough to simply treat and medicate symptoms; we need to find out the root causes to prevent their occurrence . With over 900 cases, studies and research reports on aluminum toxicity alone, CMSRI has targeted, through a strategic research agenda, an understanding of how aluminum affects the body. This large body of research supporting aluminum’s role in the development of chronic health conditions will be greatly enhanced by the results of this research, which will be peer reviewed and submitted for publication. This research is independent – free from financial conflicts of interest, and is collaborative. International teams of dedicated researchers pool their knowledge and scientific expertise to generate results that could not be achieved by a single laboratory or scientist.

According to the results already reached by CMSRI funded scientists and others concerned about aluminum toxicity, avoiding this toxin may prevent a wide array of health conditions for which other causes have not been conclusively identified. For more information, check out the video on YouTube.

Read More

Children At Risk: Aluminum Adjuvants

With over 80 years of use, the safety of aluminum adjuvants used in vaccines continues to rest on assumptions rather than scientific evidence. To date, a minimal amount of scientific evidence or research has been conducted regarding the safety of vaccines and the ingredients that come with them. That being said, recent research has shown pediatric populations suffer from unknown adverse reactions that stem from the toxicity of aluminum adjuvants.

Evidence that is available draws the conclusion that long-term persistence of aluminum adjuvants in adults can lead to cognitive dysfunction and autoimmunity. This raises the question – how does its use affect developing children? Since children and adults receive the same vaccines with the same dosage, children continue to be regularly exposed to much higher levels of aluminum adjuvants than adults because of their smaller and unique body structure.

Christopher Shaw and Lucija Tomljenovic are funded researchers of Children’s Medical Safety Research Institute and have drawn concerns regarding the use of neurotoxic substances such as aluminum as an adjuvant in pediatric vaccine formulations. The researchers urge that infants and young children should not be considered “small adults” when it comes to toxicological risks. The use of the same vaccinations should cease because children are not fully developed. The inherent risks pose developmental concerns when injecting the aluminum adjuvants because it can manipulate the autoimmune system in negative ways.

They suggest that aluminum vaccines cause multifactorial stimulatory effects on the immune system that can result in antigenic compounds failure to launch adequate immune responses. Also, during prenatal and early postnatal development, the brain is extremely vulnerable to neurotoxic insults. The development is highly sensitive and exposure to the neurotoxins will have a permeable impact to vital living functions. In addition to the early developmental stages of children and infants, ‘the immature renal system of the neonates significantly compromises their ability to eliminate environmental toxicants.’

This research should be enough evidence that children are at a higher risk of adverse reactions from aluminum adjuvants than adults. Infants and children have a unique physiology compared to adults that makes them much more vulnerable to noxious environmental insults.

Read More

George Mason University Appoints Claire Dwoskin

Claire Dwoskin was appointed to the Board of Visitors at George Mason University in the beginning of June. The university is located in Fairfax, Virginia which holds a 16 member board that exercises its authority principally in policy-making and oversight.

Dwoskin, alongside three other new appointees, will serve a four-year term starting July 1, 2014 and ending June 30, 2018. The 16 members are appointed by the Governor of Virginia, Gov. Terry McAuliffe, and serve on a rotating basis. These members are the corporate and governing body of the university that work under the leadership of a rector, vice rector and secretary.

Some of the duties Dwoskin will be responsible for include setting tuition rates, approving the university’s budget and appointing the university president. Currently, George Mason University is home to approximately 21,000 undergraduate students and 12,000 graduate students.

The Board of Visitors was established at the university in April 1972 when the school became an independent institution and has since assisted with the operations of the university. Meetings of the Board of Visitors and its committees are open to the public, except in the case of executive sessions.

With Dwoskin’s background in funding scientific research into chronic health conditions among young children and the elderly, she may be able to provide guidance on the importance of academic research as both a stimulant to economic growth and as an important factor in understanding societal and economic trends. Her family foundation has funded highly accessed research through Children’s Medical Safety Research Institute. Specifically, CMSRI is funding research into the causal factors underlying the increases in the prevalence of previously rare disorders that are becoming more frequent, such as serious autoimmune health conditions and age related disorders in the nervous system.

CMSRI is focused on discovering changes in human exposures which may be a leading cause to chronic health conditions like immune, inflammatory and cognitive disorders in children and adults ranging from asthma to neurodevelopmental disorders. Understanding the root causes is the key to preventing these conditions, as well as in developing more effective treatments and cures. Knowledge obtained through academic research funded by her foundation will likely spark new medical and therapeutic advances as well as reduce costs associated with conditions that can be prevented.

A vast amount of research has been conducted regarding the use of vaccines and their effects on the body because it is believed that some ingredients spur adverse reactions. One ingredient used in many vaccines is aluminum – which, when used as an adjuvant, has the potential to be toxic and harmful to every organ system in the body. Ms. Dwoskin will continue to support CMSRI while fulfilling board duties at George Mason University.

Read More

1 in 2 Children May Suffer From Neurological Disorder by 2025

Claire Dwoskin and Dr. Stephanie Seneff were interviewed by Leslie Carol Botha, an internationally recognized expert on women’s hormone health, to discuss the prominent issues regarding vaccinations.

Dwoskin and Dr. Seneff were in attendance at the “AutismOne: The Cutting Edge Conference” in Chicago that was held on May 21-25, 2014. The annual conference helps medical consumers become more informed on autism science and treatment which were discussed by over 100 leading scientists, experts and doctors. The conference was attended by about 1200 people, seeking educational information about autism and the latest scientific research to help them understand this neurological and immune epidemic affecting children around the world, with the highest rates being found in the United States.

AutismOne invited parents to be a part of the “Healing Autism” movement to help their children by listening to the presented findings in the conference.

Dwoskin and Dr. Seneff addressed the acknowledged increases in autoimmune and autoinflammatory conditions among young children and the elderly. Botha mentioned that she chose not to vaccinate her children upon meeting two children, 35 years ago, that were quadriplegics. Their injuries were a result of vaccinations. She mentioned that because of the concerns with unknown risks that vaccines carry with them, and the lack of information about how vaccines impact health, she became involved in the issue of vaccine safety despite not having a children affected by autism.

Dwoskin is a firm believer that funding research is playing an important role in discovering the link between adverse health conditions and vaccines. With her family foundation’s backing, researchers have discovered new information relating to the rise in chronic neurological and autoimmune conditions after vaccination. Chronic illnesses and disabilities are growing in young and elderly populations. Compared to infectious diseases, chronic health conditions are far more prevalent and costly to the US healthcare system. Finding a solution to this problem is a goal of the Dwoskin Foundation, as well as to further educate the public on vaccination injuries and adverse health consequences.

Dwoskin explains that her involvement began when one of her children suffered a vaccine injury. This injury required numerous visits for occupational therapy, vision therapy, auditory processing therapy and speech and language therapy.  Dwoskin observed many other children with a wide array of impairments while in the waiting rooms, which sparked her drive to broaden the available scientific knowledge on vaccine safety. She saw a big gap in the knowledge and science of how vaccines affect children’s overall health, which is how her family foundation began to fund research into this growing problem.

Dr. Seneff and Dwoskin want to find out the causal factors behind this growing epidemic so that scientists and clinicians can work together to prevent vaccine injuries and illnesses from occurring and develop more effective treatments and cures.  They both are concerned with the current medical model that focuses on treating symptoms rather than identifying root causes and prevention.

A main topic of discussion was the 1 in 2 (children) statistic, which as it stands now, represents the number of children diagnosed with some type of chronic health condition such as ADD, ADHD, allergies, asthma and obesity. Alarmingly, 1 in 2 will be diagnosed with a neurological disorder such as autism by 2025 if current trends continue and preventive measures are not taken. Currently in 2014, about 1 in 50 are diagnosed with autism spectrum disorder.

To listen to the full interview, visit Botha’s website where Dwoskin and Dr. Seneff discuss the details of their research.

Read More

Supporting Ground Breaking Research Achieves Results

The mission of the Dwoskin Family Foundation has always been focused on children’s health, scientific research and raising awareness of adverse reactions to vaccines. The foundation was co-founded by Claire Dwoskin, a child health activist, sponsor and trailblazer of a global  effort to address the increasing occurrence of  chronic illness and disability, including autoimmunity and age related neurological diseases.

Dwoskin is the founder of Children’s Medical Safety Research Institute (CMSRI) which provides funding for medical and scientific research  on vaccines and their ingredients. Some of the projects the institute has worked on involves the use of aluminum in vaccines. Aluminum is an experimentally demonstrated neurotoxin commonly used in vaccines and it is supposed to act as an exciting agent within the immune system.

The research points out that despite 90 years of widespread use of aluminum adjuvants, the agencies responsible for evaluating the safety of vaccines and their ingredients have not yet developed an adequate understanding about their mechanisms of action.  A significant issue is in the safety of an ingredient that medical science has limited knowledge of, and which  has shown surprisingly dangerous effects on health and ability. This research points out the harm in administering substances to children and adults without utilizing sufficiently rigorous research methods to support the safety of their inclusion in not one, but multiple vaccines administered throughout childhood. Current study designs do not assess vaccines or their ingredients for their cumulative or synergistic biological or genetic effects, or their reactivity with other substances humans are exposed to, such as glyphosate, a chemical in Roundup.

Specifically, aluminum vaccine adjuvants carry risks for autoimmunity, chronic brain inflammation and related neurological complications which may have profound and widespread negative health consequences. The research was conducted by  researchers, Dr. Lucija Tomljenovic,  and Dr. Christopher Shaw, a neuroscientist who are from the University of British Columbia in Canada. Dr. Shaw also serves as chair of the scientific advisory board at CMSRI.

In a previous study completed by Dr. Shaw, aluminum hydroxide injections were linked to motor deficits and motor neuron degeneration. This research was conducted originally to study the effects of aluminum adjuvants in anthrax and other vaccines which were used during the time of the Gulf War. Many veterans suffered from the multi-system disorder called Gulf War Syndrome (GWS). Those affected by GWS showed signs of neurological deficits including various cognitive dysfunctions and motor neuron disease.

The most likely culprit appeared to be aluminum hydroxide per the study’s conclusions, When the aluminum adjuvant was injected into mice, it resulted in motor neuron loss, motor weakness, cognitive impairments and impaired social and emotional behaviors. The mice displayed  comparable neurological deficits, cognitive dysfunctions and motor neuron disease from the same age and weight adjusted doses of aluminum hydroxide that were administered to GWS victims.

The research funded by the Dwoskin Family Foundation and now CMSRI can study vaccines for their potential causal relationships to chronic health problems that are  appearing  with increased frequency after exposure to vaccines and their toxic ingredients. Studying the effects helps  raise awareness and spread information about the harmful and adverse effects aluminum adjuvants and vaccines in general can have on the body.

Read More